Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Tredje AP fonden

Tredje AP fonden cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 115,249 shares of the pharmacy operator’s stock after selling 1,800 shares during the period. Tredje AP fonden’s holdings in Walgreens Boots Alliance were worth $1,394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in WBA. Edgestream Partners L.P. purchased a new stake in Walgreens Boots Alliance in the 2nd quarter worth approximately $655,000. Marble Harbor Investment Counsel LLC increased its holdings in Walgreens Boots Alliance by 10.4% in the second quarter. Marble Harbor Investment Counsel LLC now owns 495,073 shares of the pharmacy operator’s stock valued at $5,988,000 after buying an additional 46,525 shares in the last quarter. Plato Investment Management Ltd raised its position in shares of Walgreens Boots Alliance by 391,684.6% in the second quarter. Plato Investment Management Ltd now owns 50,932 shares of the pharmacy operator’s stock worth $616,000 after acquiring an additional 50,919 shares during the period. Thompson Siegel & Walmsley LLC boosted its stake in shares of Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after acquiring an additional 2,992,648 shares in the last quarter. Finally, Stoneridge Investment Partners LLC grew its position in shares of Walgreens Boots Alliance by 5.1% during the 2nd quarter. Stoneridge Investment Partners LLC now owns 142,643 shares of the pharmacy operator’s stock valued at $1,725,000 after acquiring an additional 6,901 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. UBS Group lowered their price target on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. Evercore ISI dropped their target price on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. Finally, TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $8.71 on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.46 and a one year high of $27.05. The stock has a market cap of $7.52 billion, a PE ratio of -1.29, a P/E/G ratio of 1.02 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The stock has a 50 day moving average price of $10.29 and a 200 day moving average price of $14.77.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The firm’s revenue was up 2.8% on a year-over-year basis. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were paid a $0.25 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 11.48%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.84%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.